BofA: Musk’s Terafab Faces Steep Hurdles, Unlikely to Dented TSMC in Near Term
BofA Securities analysts say Elon Musk’s proposed vertically integrated 'Terafab' is unlikely to meaningfully threaten Taiwan Semiconductor Manufacturing Co. (TSMC) in the near term. Key obstacles include limited process know-how, missing ecosystem components, a multi-year timeline to production and substantial capital requirements that are expecte…